Integrated Microfluidic CRISPR-Based Diagnostic Device for Rapid Testing of HPVs
Biosensors · 2026
DOI: 10.3390/bios16100571 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors, 2026. Verfasst von Tianci Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Bioinformatics Center of AMMS, Beijing 100850, China. Hauptthemen laut MEDLINE: Lab-On-A-Chip Devices, Human Papillomavirus Viruses, Biosensing Techniques. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Nova Program.
Abstract (Originalsprache)
Screening for high-risk human papillomavirus (HR-HPV) is a pivotal strategy for the prevention of invasive cervical cancer, particularly in resource-constrained settings. In this study, we developed a CRISPR-based compact automated real-time detection system, termed Ccard, for rapid testing of HPV16, HPV18, and the internal reference gene GAPDH through a streamlined workflow. A simple room-temperature treatment efficiently releases nucleic acids directly from swab samples, bypassing the need for extraction. The mixture was driven through the channels and loaded into the reaction chambers on the microfluidic chip by a vacuum pump. The lyophilized reagents in the reaction zone of the microfluidic chip were redissolved. The system subsequently performs a single-step RPA-CRISPR/Cas13a reaction, with real-time detection enabled by an Internet of Things device. The assay achieved detection within 30 min, with a limit of detection (LOD) of 5 copies/µL for both HPV16 and HPV18. Validation with clinical samples demonstrated high sensitivity (96.8% for HPV16 and 100% for HPV18) and 100% specificity. These results highlight the reliability, precision, and strong potential of the Ccard system for rapid testing of HR-HPVs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Bioinformatics Center of AMMS, Beijing 100850, China.
- The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou 450003, China.
- Department of Pathology, Air Force Medical Center, Air Force Medical University, Beijing 100142, China.
- Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
- Department of Clinical Laboratory, Air Force Medical Center, Air Force Medical University, Beijing 100142, China.
- State Key Laboratory of Kidney Diseases, Beijing 100853, China.
ORCID-Profile: Yongjun Han
Förderung
- National Natural Science Foundation of China
- Beijing Nova Program
Zitieren
APA
Wang, T., Li, L., Wang, Y., Han, Y., Li, T., Yu, C., Lou, Y., Rong, Z., Lin, K., & Wang, S. (2026). Integrated Microfluidic CRISPR-Based Diagnostic Device for Rapid Testing of HPVs. Biosensors. https://doi.org/10.3390/bios16100571
Vancouver
Wang T, Li L, Wang Y, Han Y, Li T, Yu C, et al. Integrated Microfluidic CRISPR-Based Diagnostic Device for Rapid Testing of HPVs. Biosensors. 2026. doi:10.3390/bios16100571
BibTeX
@article{Wang2026,
author = {Wang, Tianci and Li, Lingyun and Wang, Yunxiang and Han, Yongjun and Li, Teng and Yu, Chaoran and Lou, Yufeng and Rong, Zhen and Lin, Kai and Wang, Shengqi},
title = {Integrated Microfluidic CRISPR-Based Diagnostic Device for Rapid Testing of HPVs},
journal = {Biosensors},
year = {2026},
doi = {10.3390/bios16100571}
}
EUVIMED